Search Results - "BASSISSI, Firas"
-
1
Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification
Published in Frontiers in pharmacology (07-02-2024)“…Patients receiving dialysis have high cardiovascular risk in part due to extensive vascular calcification. In the CaLIPSO study, infusion of hexasodium fytate…”
Get full text
Journal Article -
2
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition
Published in Therapeutic advances in chronic disease (2020)“…Background: Hepatic fibrosis is the result of chronic liver injury that can progress to cirrhosis and lead to liver failure. Nevertheless, there are no…”
Get full text
Journal Article -
3
Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves
Published in Veterinary parasitology (25-03-2008)“…Belgian Blue (BB) cattle are very sensitive to mange caused by Psoroptes ovis and, in contrast to the case in Holstein cattle, single treatments with…”
Get full text
Journal Article -
4
Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics
Published in Pharmaceutical research (01-11-2006)“…We studied the influence of dyslipemia on the distribution of moxidectin, a potent antiparasitic drug of the macrocyclic lactone (ML) family, in plasma…”
Get full text
Journal Article -
5
The FIPO23 trial: First-in-human phase I/II study of XON7 in advanced solids tumors
Published in Journal of clinical oncology (01-06-2024)“…TPS2673 Background: XON7 is a first-in-class glyco-humanized polyclonal antibody (GH-pAb) targeting selectively multiple tumor-associated antigens. XON7…”
Get full text
Journal Article -
6
Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans
Published in Comparative biochemistry and physiology. Toxicology & pharmacology (01-08-2004)“…We studied the in vitro distribution of macrocyclic lactones (MLs), lipophilic anthelmintic drugs, in the plasma of several animal species including humans…”
Get full text
Journal Article -
7
-
8
-
9
Abstract 2739: XON27, a novel and potent immunotherapy against hematologic malignancies
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Background: Over the past decades, intensive research has led to the development of innovative therapies (monoclonal and bispecific antibodies, CAR T cells)…”
Get full text
Journal Article -
10
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions
Published in Autophagy (04-03-2022)“…Hepatocellular carcinoma is the most frequent primary liver cancer. Macroautophagy/autophagy inhibitors have been extensively studied in cancer but, to date,…”
Get full text
Journal Article -
11
Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration
Published in Parasitology research (1987) (01-02-2006)“…Ivermectin is a member of the macrocyclic lactone family widely used in livestock, pets, and humans as a potent parasiticide. Slight differences in formulation…”
Get full text
Journal Article -
12
Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs
Published in European journal of pharmaceutical sciences (2006)“…Moxidectin, a macrocyclic lactone (ML), is a potent parasiticide widely used in veterinary medicine and currently under development for use in humans. The…”
Get full text
Journal Article -
13
P1234SNF472 IMPROVES LIMB BLOOD PERFUSION AND WALKING ABILITY IN A PERIPHERAL ARTERY DISEASE VASCULAR CALCIFICATION RAT MODEL
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims Peripheral Artery disease (PAD) is a common vascular disease associated with functional impairment and increased risk of…”
Get full text
Journal Article -
14
P0884MYO-INOSITOL HEXAPHOSPHATE PEGYLATION IMPROVES BIOAVAILABILITY BUT REDUCES ITS ANTI-VASCULAR CALCIFICATION EFFECT IN RATS
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims Vascular calcification (VC) is a major contributor to increased morbidity and mortality in End Stage Kidney Disease (ESKD)…”
Get full text
Journal Article -
15
Pharmacokinetics, Pharmacodynamics (PK-PD), and Exposure-Efficacy Evaluation from CaLIPSO, a Phase 2B Study to Assess the Effect of SNF472 on Progression of Cardiovascular Calcification in Patients on Hemodialysis: PO1142
Published in Journal of the American Society of Nephrology (01-10-2020)Get full text
Journal Article -
16
Assessment of Vascular Calcification Using Micro-CT Quantification in a Vitamin D Rat Model: PO0527
Published in Journal of the American Society of Nephrology (01-10-2021)Get full text
Journal Article -
17
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma
Published in Investigational new drugs (01-12-2019)“…Summary Among the acquired modifications in cancer cells, changes in lysosomal phenotype and functions are well described, making lysosomes a potential target…”
Get full text
Journal Article -
18
Clinical significance of high expression of a specific solute carrier transporter in HCC
Published in Journal of clinical oncology (01-02-2018)“…Abstract only 303 Background: Hepatocellular carcinoma (HCC) is the third cause of cancer-related death. GNS561 (Genoscience Pharma, France) is a small…”
Get full text
Journal Article -
19
Enhancement of oral moxidectin bioavailability in rabbits by lipid co-administration
Published in Parasitology research (1987) (01-10-2004)“…Moxidectin is a member of the macrocyclic lactone family of drugs widely used for the control of internal and external parasites. Because moxidectin is highly…”
Get full text
Journal Article -
20
Abstract 2737: LIS22, a first in class polyclonal antibody immunotherapy in T cell blood cancers
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Background: Several approaches such as antibody drug conjugate (ADC), chimeric antigen receptor T cells (CAR-T) and recently bispecific antibodies are being…”
Get full text
Journal Article